Study #ANS00-339
PSYCHOPHYSICAL STUDIES OF CANCER AND CHEMOTHERAPY-INDUCED PAIN.
MD Anderson Study Status
Enrolling
Treatment Agent
Description
The Aim of this Study is to examine the feasibility of using quantitative sensory testing procedures, widely applied to the experimental study of sensory processing in humans both with and without various pain syndromes, to now characterize the psychophysical properties of neuropathic pain that has developed as a consequence of cancer therapy. Skin punch biopsies will be performed in patients with chemotherapy-induced pain to determine whether the impairment of nerve function is due to actual retraction or loss of innervation to the skin in areas affected by sensory disturbance.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Advanced Cancer;Pain
Study phase:
Physician name:
Patrick Dougherty
Department:
Pain Medicine
For general questions about clinical trials:
1-844-829-9300
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.